INNOVAGE HOLDING CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.72 USD | -4.86% |
|
-7.69% | -38.00% |
| 04-24 | InnovAge Holding Corp. Launches PACE Center in Los Angeles | CI |
| 03-13 | JPMorgan Adjusts Price Target on InnovAge to $6 From $7, Maintains Neutral Rating | MT |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -38.00% | 531M | C- | ||
| -14.58% | 84.68B | B- | ||
| +15.05% | 81.12B | C+ | ||
| +10.49% | 29.59B | C+ | ||
| -10.17% | 16.73B | B | ||
| -1.39% | 16.36B | A- | ||
| -31.58% | 11.77B | - | - | |
| +1.82% | 11.72B | A- | ||
| +31.86% | 11.71B | B- | ||
| -0.47% | 11.66B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- INNV Stock
- Ratings InnovAge Holding Corp.
